Viewing Study NCT02975934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-02-21 @ 5:49 AM
Study NCT ID: NCT02975934
Status: COMPLETED
Last Update Posted: 2025-07-25
First Post: 2016-11-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Sponsor: pharmaand GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration Resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CRPC View
None PARP inhibitor View
None PARPi View
None BRCA View
None ATM View
None HRD View
None TRITON View
None homologous recombination View
None DNA repair View
None DNA defect View
None DNA anomaly View
None germline View
None somatic View
None mCRPC View